1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Spectrum Pharmaceuticals Announces Outstanding ZEVALIN … – EON: Enhanced Online News (press release)

June 19, 2012Monoclonal Anti-CD20 Antibodiesadmin

Proactive Investors USA & Canada

Spectrum Pharmaceuticals Announces Outstanding ZEVALIN ...
EON: Enhanced Online News (press release)
The ZEVALIN therapeutic regimen consists of two components: rituximab, and ... Deaths have occurred within 24 hours of rituximab infusion, an essential ...
Spectrum Pharmaceuticals Announces Outstanding ZEVALIN(R ...MarketWatch (press release)
New clinical data for ZEVALIN Injection for intravenous use ...News-Medical.net

all 15 news articles »

Post navigation

← Survival rates lower for heart transplant patients whose arteries … – HealthCanal.com Donating loved one's organs can bring solace, families say →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos